PUBLISHER: The Business Research Company | PRODUCT CODE: 1669588
PUBLISHER: The Business Research Company | PRODUCT CODE: 1669588
Electroceuticals constitute a field in medical science and technology that employs electrical stimulation to modulate and engage with the body's neural circuits and bioelectrical systems for therapeutic purposes. This interdisciplinary approach combines electronics, biology, and medical principles to create devices and therapies targeting specific nerves, tissues, or organs, offering treatment for various medical conditions.
The primary categories of electroceuticals include implantable electroceutical devices and non-invasive electroceutical devices. Implantable electroceutical devices are medical devices positioned inside the body to administer electrical stimulation or therapy directly to targeted tissues or organs, enabling precise and localized treatment. The range of products encompasses implantable cardioverter defibrillators, cardiac pacemakers, cochlear implants, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. These devices find application in treating conditions such as arrhythmia, depression, Parkinson's disease, tremor, epilepsy, sensorineural hearing loss, among others, and are utilized by end-users including hospitals, ambulatory surgical centers, diagnostic centers, and others.
The electroceuticals research report is one of a series of new reports from The Business Research Company that provides electroceuticals market statistics, including the electroceuticals industry's global market size, regional shares, competitors with an electroceuticals market share, detailed electroceuticals market segments, market trends, and opportunities, and any further data you may need to thrive in the electroceuticals industry. This electroceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The electroceuticals market size has grown strongly in recent years. It will grow from $22.76 billion in 2024 to $24.19 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rise in chronic diseases, investment in research and development, aging population, advancements in nanotechnology, improved understanding of neural pathways
The electroceuticals market size is expected to see strong growth in the next few years. It will grow to $33.49 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to advancements in bioelectronics, precision medicine development, growth in non-invasive therapies, focus on chronic pain management, rising neurological disorders. Major trends in the forecast period include implantable bioelectronic devices, wireless and remote-controlled devices, personalized electroceutical therapies, advancements in neural modulation techniques, bioelectronic devices for metabolic disorders.
The anticipated growth of the electroceuticals market is driven by the high prevalence of chronic diseases. Chronic diseases, characterized by persistent or long-lasting health conditions, are expected to affect a substantial number of individuals aged 50 and older in the United States, reaching 142.66 million by 2050, according to the National Library of Medicine. Electroceuticals play a crucial role in managing chronic diseases, providing personalized neuromodulation, and offering long-term solutions to address treatment resistance.
The electroceuticals market is poised for growth due to the increasing prevalence of neurological disorders. Neurological disorders, affecting the nervous system, impact a significant portion of the global population. According to The European Academy of Neurology, one in three individuals may experience a neurological disorder at some point in their lives. Furthermore, the World Health Organization reports that epilepsy, a prevalent neurological disorder, affects over 50 million people worldwide, with approximately 80% of cases found in low- and middle-income countries. The application of electroceuticals in modulating the nervous system's activity, reducing side effects, and enabling long-term disease management contributes to the market's expansion.
Major companies in the electroceuticals market are prioritizing the development of innovative products, such as over-the-counter (OTC) bioelectric bandages, to accelerate healing and enhance patient care. An OTC bioelectric bandage is a specialized wound care product designed to promote faster healing through bioelectric technology. For example, in April 2024, Vomaris Medical, a U.S.-based company focused on innovative medical devices and technologies, launched PowerHeal bioelectric bandages for over-the-counter use. These bandages aim to accelerate healing and reduce infection risks for superficial wounds like minor cuts, scrapes, and blisters. PowerHeal bioelectric bandages can revolutionize wound care by speeding up healing by 2 to 3 times compared to traditional methods. They effectively eliminate up to 99.99% of bacteria, including antibiotic-resistant strains, thereby reducing infection risks without the use of antibiotics. Additionally, these bandages create an optimal moist environment that promotes healing while minimizing pain and scarring.
Major players in the electroceuticals market are emphasizing innovative treatments, including advanced non-invasive neuromodulation. This form of treatment targets deep brain structural dysfunctions associated with chronic ailments, particularly central nervous system diseases and overactive bladder. Stimvia, a US-based medical technology company, exemplifies this approach with the launch of uris in September 2023. Uris technology stands out for its ability to precisely stimulate specific nerves through novel electrodes placed on the patient's skin, delivering electric signals directly to the brain. Employing peroneal neuromodulation, this technique involves stimulating peripheral nerves connecting the brain and spinal cord to the extremities, showcasing promising outcomes in clinical trials for conditions such as overactive bladder.
In August 2023, DuPont, a U.S.-based science company focused on creating sustainable solutions through science and innovation, acquired Spectrum Plastics for an undisclosed amount. This acquisition aims to enhance DuPont's healthcare portfolio, expand into rapidly growing therapeutic areas, and leverage advanced manufacturing capabilities to drive innovation and revenue growth in the medical device market. Spectrum Plastics, also based in the U.S., specializes in manufacturing biocompatible materials that are essential for the development of electroceuticals, thereby enhancing innovative medical treatments.
Major companies operating in the electroceuticals market include Medtronic Public Limited Company, Boston Scientific Corporation, Sonova Holding AG, Biotronik SE & Co. KG, Cochlear Limited, LivaNova PLC, MicroPort Scientific Corporation Limited, MED-EL Elektromedizinische Gerate GmbH, Nevro Corporation, Axonics Modulation Technologies Inc., Oticon Medical, Neuronetics Inc., Nuvectra Corporation, NeuroPace Inc., Second Sight Medical Products Inc, Saluda Medical Pty. Ltd., Stimwave Technologies Incorporated, electroCore Inc., Synapse Biomedical Inc., Soterix Medical Inc., Retina Implant AG, MicroTransponder Inc., Vomaris Innovations Inc., SPR Therapeutics Inc., NeuroSigma Inc., Nexeon MedSystems Inc., BioElectronics Corporation, Setpoint Medical Corporation, Endonovo Therapeutics Inc.
North America was the largest region in the electroceuticals market in 2024. The regions covered in the electroceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the electroceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The electroceuticals market consists of revenues earned by entities by providing services, including clinical support, surgical implantation procedures, programming and adjustment of devices, patient monitoring, and post-implantation care. The market value includes the value of related goods sold by the service provider or included within the service offering. The electroceuticals market also includes sales of wearable electroceuticals, electroceutical drug delivery systems, electroceutical sleep devices, and gastric electrical stimulators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Electroceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on electroceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for electroceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The electroceuticals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.